These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 27096417)
1. Analyzing Gastric Lavage of Gastric Cancer Patients: A Prospective Observational Study on Cytopathology and Determination of Intragastric CEA, CA 19.9, CA 72.4, and CA 50. Virgilio E; Giarnieri E; Montagnini M; D''Urso R; Proietti A; Mesiti A; Giovagnoli MR; Mercantini P; Cavallini M; Balducci G Acta Cytol; 2016; 60(2):161-6. PubMed ID: 27096417 [TBL] [Abstract][Full Text] [Related]
2. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022 [TBL] [Abstract][Full Text] [Related]
3. Combined Analysis of Intragastric Malignant Exfoliation and Ca 72.4 Concentration in Stomach Adenocarcinoma: The "GL1 Ca 72.4" Parameter. Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Villani S; Proietti A; D'Urso R; Cardelli P; Balducci G; Cavallini M Acta Cytol; 2020; 64(6):563-571. PubMed ID: 32526755 [TBL] [Abstract][Full Text] [Related]
4. The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy. Kim DH; Oh SJ; Oh CA; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S J Surg Oncol; 2011 Nov; 104(6):585-91. PubMed ID: 21695697 [TBL] [Abstract][Full Text] [Related]
5. Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test. Wang HJ; He XJ; Ma YY; Jiang XT; Xia YJ; Ye ZY; Zhao ZS; Tao HQ Anat Rec (Hoboken); 2010 Nov; 293(11):1855-63. PubMed ID: 20730863 [TBL] [Abstract][Full Text] [Related]
6. CEA and CA 19-9 are still valuable markers for the prognosis of colorectal and gastric cancer patients. Sisik A; Kaya M; Bas G; Basak F; Alimoglu O Asian Pac J Cancer Prev; 2013; 14(7):4289-94. PubMed ID: 23991991 [TBL] [Abstract][Full Text] [Related]
7. Receiver operating characteristic (ROC) curve analysis of the tumor markers CEA, CA 19-9 and CA 72-4 in gastric cancer. Fernández-Fernández L; Tejero E; Tieso A; Rabadán L; Munoz M; Santos I Int Surg; 1996; 81(4):400-2. PubMed ID: 9127805 [TBL] [Abstract][Full Text] [Related]
8. Predicting Peritoneal Carcinomatosis in Locally Advanced Gastric Cancer: The Significance of Tumor Markers in the Peritoneal Washing. Pinheiro JL; Duarte L; Santos AJ; Tojal A; Canhoto C; Ferreira M; Marques C; Pereira J J Gastrointest Cancer; 2024 Mar; 55(1):427-434. PubMed ID: 37966631 [TBL] [Abstract][Full Text] [Related]
9. Detection of cancer cells and tumor markers in gastric lavage of patients with gastric cancer: Do these findings have a clinicopathological significance and oncological implication? Virgilio E; Giarnieri E; Montagnini M; D'Urso R; Proietti A; Mesiti A; Giovagnoli MR; Mercantini P; Cavallini M; Balducci G Med Hypotheses; 2016 Sep; 94():1-3. PubMed ID: 27515187 [TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. Sun Z; Zhang N World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer. Kim JH; Jun KH; Jung H; Park IS; Chin HM Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088 [TBL] [Abstract][Full Text] [Related]
12. Presence of cancer cells in gastric lavage of gastric cancer patients as an indicator of advanced disease, predictor of tumour aggressive phenotype and independent prognostic factor for poor survival: The endoluminal metastatic pathway of gastric cancer and GL0/GL1 classification. Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Nigri G; Mercantini P; Ramacciato G; Cavallini M; Balducci G Cytopathology; 2018 Feb; 29(1):41-48. PubMed ID: 29063636 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer. Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811 [TBL] [Abstract][Full Text] [Related]
14. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer. Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma. Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients. Wang W; Seeruttun SR; Fang C; Chen J; Li Y; Liu Z; Zhan Y; Li W; Chen Y; Sun X; Li Y; Xu D; Guan Y; Zhou Z Ann Surg Oncol; 2016 Apr; 23(4):1244-51. PubMed ID: 26620645 [TBL] [Abstract][Full Text] [Related]
17. CEA/CA72-4 levels in peritoneal lavage fluid are predictive factors in patients with gastric carcinoma. Yamamoto M; Yoshinaga K; Matsuyama A; Tsutsui S; Ishida T J Cancer Res Clin Oncol; 2014 Apr; 140(4):607-12. PubMed ID: 24509654 [TBL] [Abstract][Full Text] [Related]
18. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Lai IR; Lee WJ; Huang MT; Lin HH Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226 [TBL] [Abstract][Full Text] [Related]
19. In Pursuit of Novel Markers: Unraveling the Potential of miR-106, CEA and CA 19-9 in Gastric Adenocarcinoma Diagnosis and Staging. Boicean A; Boeras I; Birsan S; Ichim C; Todor SB; Onisor DM; Brusnic O; Bacila C; Dura H; Roman-Filip C; Ognean ML; Tanasescu C; Hasegan A; Bratu D; Porr C; Roman-Filip I; Neamtu B; Fleaca SR Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063140 [TBL] [Abstract][Full Text] [Related]
20. A system for tumor heterogeneity evaluation and diagnosis based on tumor markers measured routinely in the laboratory. Hui L; Rixv L; Xiuying Z Clin Biochem; 2015 Dec; 48(18):1241-5. PubMed ID: 26216289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]